Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$1.52B
Total Bought:
$215.89M
Total Sold:
$112.10M
Net Transaction:
+$103.79M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)2,042,4712,022,098-20,373$259.29M$320.10M21.11%+$60.81M
Vaxcyte, Inc.(PCVX)1,039,2882,336,796+1,297,508$118.76M$191.29M12.62%+$72.53M
Celldex Therapeutics, Inc.(CLDX)3,458,6095,064,207+1,605,598$117.56M$127.97M8.44%+$10.41M
Syndax Pharmaceuticals, Inc.(SNDX)5,842,9258,520,000+2,677,075$112.48M$112.63M7.43%+$158.1K
Dynavax Technologies Corp8,332,6876,560,835-1,771,852$92.83M$83.78M5.53%-$9.04M
CG Oncology, Inc.(CGON)1,770,8052,519,705+748,900$66.81M$72.27M4.77%+$5.45M
Cogent Biosciences, Inc.(COGT)9,239,7319,105,000-134,731$99.79M$71.02M4.68%-$28.77M
BioCryst Pharmaceuticals, Inc.(BCRX)9,085,3689,085,3680$69.05M$68.32M4.51%-$726.8K
Viridian Therapeutics, Inc.(VRDN)2,511,2953,326,262+814,967$57.13M$63.76M4.21%+$6.63M
Vera Therapeutics, Inc.CL A(VERA)1,576,5491,457,910-118,639$69.68M$61.66M4.07%-$8.03M
Wave Life Sciences, Inc.SHS(WVE)4,899,4974,899,4970$40.18M$60.61M4.00%+$20.43M
Beam Therapeutics Inc.(BEAM)1,302,0851,756,158+454,073$31.90M$43.55M2.87%+$11.65M
Immunocore Holdings plcADS(IMCR)01,225,576+1,225,576$0$36.15M2.38%+$36.15M
Engene Holdings Inc
COM
1,736,2274,994,090+3,257,863$11.46M$33.21M2.19%+$21.75M
Travere Therapeutics, Inc.(TVTX)1,371,5111,802,750+431,239$19.19M$31.40M2.07%+$12.22M
Liquidia Corporation(LQDA)2,266,3282,266,3280$22.66M$26.65M1.76%+$3.99M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)3,685,5634,685,563+1,000,000$15.18M$20.76M1.37%+$5.57M
2seventy Bio Inc5,953,8255,953,8250$28.10M$17.50M1.15%-$10.60M
Cullinan Therapeutics, Inc.(CGEM)01,252,738+1,252,738$0$15.26M1.01%+$15.26M
Protagonist Therapeutics Inc456,369390,792-65,577$20.54M$15.08M1.00%-$5.45M
Tyra Biosciences, Inc.(TYRA)467,947530,478+62,531$11.00M$7.37M0.49%-$3.63M
Burning Rock Biotech LimitedADS(BNR)989,217994,883+5,666$3.23M$6.72M0.44%+$3.49M
Sutro Biopharma, Inc.(STRO)2,066,4473,641,447+1,575,000$7.15M$6.70M0.44%-$449.6K
Amarin Corp PlcADR12,414,62812,414,6280$7.78M$6.02M0.40%-$1.76M
Proqr Thrapeutics N VSHS EURO
SHS EURO
01,750,000+1,750,000$0$4.64M0.31%+$4.64M
Relay Therapeutics, Inc.(RLAY)01,000,000+1,000,000$0$4.12M0.27%+$4.12M
Caribou Biosciences, Inc.(CRBU)2,356,1472,406,147+50,000$4.62M$3.83M0.25%-$792.3K
Acelyrin Inc847,366847,3660$4.18M$2.66M0.18%-$1.52M
Climb Bio, Inc.(CLYM)0547,000+547,000$0$984.6K0.06%+$984.6K
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q4 2024 | TickerTrail